Physician profile
Matthew Jay Claxton
NPI 1457466989
$4,827.53
in general payments reported to CMS, 2019-2025
19 companies · $199 in 2025
The $199 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $1,248 · 2021: $349 · 2022: $226 · 2023: $1,754 · 2024: $555 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,631 · Travel and Lodging: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.27 |
| Travel and Lodging | $876.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,548.04 | 2019-2023 | |
| Organogenesis INC. | $1,074.53 | 2019-2024 | Puraply, Affinity, Apligraf |
| Elite Orthopedics, LLC | $1,007.68 | 2021-2024 | |
| Stryker Corporation | $209.54 | 2020-2025 | N/A, Viaflow, Citrefix |
| Convatec INC. | $182.39 | 2023-2024 | |
| Avita Medical Americas, LLC | $149.54 | 2025 | Recell |
| Arthrosurface Incorporated | $148.23 | 2019 | |
| Amgen INC. | $124.99 | 2024 | Krystexxa |
| Wright Medical Technology, INC. | $109.97 | 2019-2020 | |
| Cardiovascular Systems INC. | $49.37 | 2022 | |
| Paragon 28, INC. | $38.76 | 2019-2020 | |
| Integra Lifesciences Corporation | $37.41 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $31.72 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Averitas Pharma INC. | $24.08 | 2023 | Qutenza |
| Paratek Pharmaceuticals, INC. | $21.73 | 2023 | Nuzyra |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $20.90 | 2022 | |
| Melinta Therapeutics, LLC | $16.90 | 2019 | |
| Nextremity Solutions INC. | $16.67 | 2020 | |
| Zimmer Biomet Holdings, INC. | $15.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Claxton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.